Navigation Links
Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted
Date:7/22/2014

ces Group Analyst Emma McFadden, Ph.D.:

  • "Although it is still uncertain when, or even if, generic versions of Teva's Copaxone 20 mg will be approved by the FDA, neurologists indicated that they plan to switch approximately one-fifth of audit patients to generic glatiramer acetate once available. While it is not surprising that Copaxone 20 mg appears to be most at risk for generic switching, it is interesting to note that Tecfidera- and Tysabri-treated patients appear to be least likely to be switched, alluding to neurologists' perception that these products have characteristics that justify the additional cost or reimbursement effort."
  • "Analysis of candidates for the emerging monoclonal antibodies Genzyme/Sanofi's Lemtrada and Genentech/Roche's ocrelizumab suggests that these DMTs would likely be prescribed to patients with more severe/aggressive MS and potentially compete with Tysabri, the DMT typically initiated when efficacy reasons are the main drivers of brand choice. Given Tysabri's general position in the MS treatment algorithm as a third-line or later option, these emerging agents will be reserved primarily for patients who have failed earlier lines of therapy."

About Decision Resources Group
Decision Resources Group offers best-in-class, high-value information and insights on critical issues within the healthcare industry. Clients rely on this analysis and data to make informed decisions. Find out more at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Decision Resources Group
Christopher Comfort
781-993-2597
ccomfort@dresourcesg
'/>"/>

SOURCE Decision Resources Group
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited First Quarter 2012 Results
2. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
3. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
4. Sinovac Reports Unaudited First Quarter 2012 Financial Results
5. SCOLR Pharma Announces Unaudited Net Sales of Nutritional Products
6. 3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
7. Techne Corporation Releases Unaudited Fourth Quarter And Fiscal Year 2012 Results
8. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
9. Simcere Pharmaceutical Group Reports Preliminary Unaudited Second Quarter 2012 Results
10. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
11. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... -- BioSpecifics Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... XIAFLEX ® in the U.S. and XIAPEX ® ... Tom Wegman , will present a corporate overview ... The presentation will take place on Monday, June ... New York, NY . A live webcast of ...
(Date:5/26/2015)... May 26, 2015 ViiV Healthcare, ... (CHAI) announced today that Aurobindo Pharma has submitted an ... Tentative Approval, to the Food and Drug Administration (FDA), ... ANDA for a generic version of dolutegravir, less than ... sale in the United States . ...
(Date:5/26/2015)... Israel , May 26, 2015 /PRNewswire/ ... Dario™ Diabetes Management Solution, announced today that ... leading HMO, Maccabi Healthcare, it has ... as part of Maccabi,s advanced Telecare unit ... diabetes management solution that enables remote treatment ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the Jefferies 2015 Healthcare Conference 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 2ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 3ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 4ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 5ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 6ViiV Healthcare and CHAI Collaboration Delivers Second Milestone With First Filing With the FDA of Generic Dolutegravir by Aurobindo Pharma for the Treatment of HIV 7LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
... Sept. 15, 2011 meridianEMR ® , the ... Records (EHR) for Urology, announces that its Advanced ... and other unusual activities on a practice,s meridianEMR ... Urology practice to respond immediately in protecting patient ...
... The Liver Meeting ® is the premier meeting ... findings on new drugs, novel treatments, and the results from ... Americans have some form of liver disease, but fortunately, the ... developing new treatments for patients.   At this ...
Cached Medicine Technology:meridianEMR Advanced Monitoring System Catches Security Breach 2meridianEMR Advanced Monitoring System Catches Security Breach 3The 62nd Annual Meeting of the American Association for the Study of Liver Diseases 2
(Date:5/26/2015)... Corner, VA (PRWEB) May 26, 2015 ... critical technology and management consulting solutions to the federal ... Technology Strategy and Cloud Solutions. In this newly created ... strategic capabilities and growth in cloud computing, big data, ... join our expanding leadership team as we continue to ...
(Date:5/26/2015)... Norcross, GA (PRWEB) May 26, 2015 ... its line of fresh, all-natural dog foods are now ... Dog Market in Atlanta and The Good Old Dog ... Norcross, Georgia where they’ve recently opened a state-of-the-art, climate ... farmers and farmers’ markets and all of the food ...
(Date:5/26/2015)... New Brunswick (PRWEB) May 26, 2015 ... announce the successful upgrade of the DMi Partners ... This version was the first in Indosoft's contact center ... API improvements, added screen support for such trunk features ... screens, improved lead management, and included upgrades to ...
(Date:5/26/2015)... San Antonio, TX (PRWEB) May 26, 2015 ... announce the opening of its newest clinic on May 25, ... found at 1919 Rogers Road, Suite 102 in Westover Hills ... late as 7 P.M. , “We’re thrilled about opening ... to reach more of our neighbors in San Antonio and ...
(Date:5/26/2015)... 2015 ProTrailer Network is a new ... Pro X . This Effect includes 30 all ... styled text. , ProTrailer Network allows users to ... can easily complement any form of media project. FCPX ... can make professional looking openers. , ProTrailer Network includes ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group (Octo) Appoints Gaurav “GP” Pal as Vice President of Technology Strategy and Cloud Solutions 2Health News:Allprovide, the All-Natural Pet Food, Available At Georgia Retailers 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 2Health News:DMi Partners Upgrades to Indosoft Q-Suite 5.8 3Health News:TexPTS Announces New Clinic in San Antonio 2Health News:Developers at Pixel Film Studios Release ProTrailer Network for Final Cut Pro X 2
... pleased,to announce that Linda F. Newman, RN, an attorney ... 17, 2008., Ms. Newman is a member of ... health care and professional liability issues,including the defense of ... nursing and pharmacists; and long term care facilities.,She has ...
... Therapy Appears Superior to Standard Therapy for Eradicating ... controlled trials comparing sequential and standard triple therapies ... pylori infection found that sequential therapy appears superior ... pylori infection. , Authors say if further ...
... Zimmer Holdings, Inc.,(NYSE: ZMH ; SWX: ... joined the,Company as Group President, Global Businesses. He ... Trauma, Zimmer Orthopaedic Surgical,Products, Zimmer Computer Assisted Solutions ... to David Dvorak, Zimmer Holdings,President and Chief Executive ...
... IT Integration Company Provides Development Expertise for Partners ... Developing on the Google Health Platform, ... privately held information and development company, announced,collaboration today with Google ... Health was launched to the public at an,event at Google,s ...
... polyalkylimide implant injections leaves skin open to infection, study ... Cosmetic skin fillers called polyalkylimide implant injections may cause ... treatment, Spanish researchers warn. , These implants, which ... procedures for facial features such as the lips, cheeks, ...
... risk in diabetic men , , MONDAY, May 19 (HealthDay News) ... to the evidence that erectile dysfunction can be a powerful ... Kong study of 2,306 men with diabetes but no signs ... the start were 58 percent more likely to have a ...
Cached Medicine News:Health News:SmithAmundsen Elects New Partner, Linda F. Newman 2Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 2Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 3Health News:Zimmer Holdings Names Mark C. Throdahl Group President, Global Businesses 4Health News:Mount Tabor Collaborates with Google Health 2Health News:Cosmetic Skin Fillers May Cause Delayed Side Effects 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 2Health News:Erectile Dysfunction a Strong Harbinger of Heart Trouble 3
... QuickScreen™ At Home Drug Test is the first ... for home use. The kit includes a rapid ... read instructions, a handbook with frequently asked questions ... sample to the laboratory if the screening device ...
... products, SEDIPLAST® is a completely closed ... protect laboratory personnel from the risk ... a uniquely designed erythrocyte sedimentation rate ... and convenience as well as reliable ...
The screening test for colorectal cancer that's simple, convenient, and effective....
... Hemoccult SENSA fecal occult blood tests ... medical practice as a way to ... stool specimens, an early indication of ... that annual screening with Hemoccult will ...
Medicine Products: